Global Crohn’s Disease Therapeutics Market Insights and Forecast to 2028

Report ID: 1750234 | Published Date: Jan 2025 | No. of Page: 106 | Base Year: 2024 | Rating: 4.2 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Business Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Crohn’s Disease Therapeutics Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Non-Surgical
        1.2.3 Surgical
    1.3 Market by Application
        1.3.1 Global Crohn’s Disease Therapeutics Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Hospitals
        1.3.3 Ambulatory Surgical Centers
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Crohn’s Disease Therapeutics Market Perspective (2017-2028)
    2.2 Crohn’s Disease Therapeutics Growth Trends by Region
        2.2.1 Crohn’s Disease Therapeutics Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Crohn’s Disease Therapeutics Historic Market Size by Region (2017-2022)
        2.2.3 Crohn’s Disease Therapeutics Forecasted Market Size by Region (2023-2028)
    2.3 Crohn’s Disease Therapeutics Market Dynamics
        2.3.1 Crohn’s Disease Therapeutics Industry Trends
        2.3.2 Crohn’s Disease Therapeutics Market Drivers
        2.3.3 Crohn’s Disease Therapeutics Market Challenges
        2.3.4 Crohn’s Disease Therapeutics Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Crohn’s Disease Therapeutics Players by Revenue
        3.1.1 Global Top Crohn’s Disease Therapeutics Players by Revenue (2017-2022)
        3.1.2 Global Crohn’s Disease Therapeutics Revenue Market Share by Players (2017-2022)
    3.2 Global Crohn’s Disease Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Crohn’s Disease Therapeutics Revenue
    3.4 Global Crohn’s Disease Therapeutics Market Concentration Ratio
        3.4.1 Global Crohn’s Disease Therapeutics Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Crohn’s Disease Therapeutics Revenue in 2021
    3.5 Crohn’s Disease Therapeutics Key Players Head office and Area Served
    3.6 Key Players Crohn’s Disease Therapeutics Product Solution and Service
    3.7 Date of Enter into Crohn’s Disease Therapeutics Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Crohn’s Disease Therapeutics Breakdown Data by Type
    4.1 Global Crohn’s Disease Therapeutics Historic Market Size by Type (2017-2022)
    4.2 Global Crohn’s Disease Therapeutics Forecasted Market Size by Type (2023-2028)
5 Crohn’s Disease Therapeutics Breakdown Data by Application
    5.1 Global Crohn’s Disease Therapeutics Historic Market Size by Application (2017-2022)
    5.2 Global Crohn’s Disease Therapeutics Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Crohn’s Disease Therapeutics Market Size (2017-2028)
    6.2 North America Crohn’s Disease Therapeutics Market Size by Type
        6.2.1 North America Crohn’s Disease Therapeutics Market Size by Type (2017-2022)
        6.2.2 North America Crohn’s Disease Therapeutics Market Size by Type (2023-2028)
        6.2.3 North America Crohn’s Disease Therapeutics Market Share by Type (2017-2028)
    6.3 North America Crohn’s Disease Therapeutics Market Size by Application
        6.3.1 North America Crohn’s Disease Therapeutics Market Size by Application (2017-2022)
        6.3.2 North America Crohn’s Disease Therapeutics Market Size by Application (2023-2028)
        6.3.3 North America Crohn’s Disease Therapeutics Market Share by Application (2017-2028)
    6.4 North America Crohn’s Disease Therapeutics Market Size by Country
        6.4.1 North America Crohn’s Disease Therapeutics Market Size by Country (2017-2022)
        6.4.2 North America Crohn’s Disease Therapeutics Market Size by Country (2023-2028)
        6.4.3 U.S.
        6.4.4 Canada
7 Europe
    7.1 Europe Crohn’s Disease Therapeutics Market Size (2017-2028)
    7.2 Europe Crohn’s Disease Therapeutics Market Size by Type
        7.2.1 Europe Crohn’s Disease Therapeutics Market Size by Type (2017-2022)
        7.2.2 Europe Crohn’s Disease Therapeutics Market Size by Type (2023-2028)
        7.2.3 Europe Crohn’s Disease Therapeutics Market Share by Type (2017-2028)
    7.3 Europe Crohn’s Disease Therapeutics Market Size by Application
        7.3.1 Europe Crohn’s Disease Therapeutics Market Size by Application (2017-2022)
        7.3.2 Europe Crohn’s Disease Therapeutics Market Size by Application (2023-2028)
        7.3.3 Europe Crohn’s Disease Therapeutics Market Share by Application (2017-2028)
    7.4 Europe Crohn’s Disease Therapeutics Market Size by Country
        7.4.1 Europe Crohn’s Disease Therapeutics Market Size by Country (2017-2022)
        7.4.2 Europe Crohn’s Disease Therapeutics Market Size by Country (2023-2028)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Crohn’s Disease Therapeutics Market Size (2017-2028)
    8.2 Asia-Pacific Crohn’s Disease Therapeutics Market Size by Type
        8.2.1 Asia-Pacific Crohn’s Disease Therapeutics Market Size by Type (2017-2022)
        8.2.2 Asia-Pacific Crohn’s Disease Therapeutics Market Size by Type (2023-2028)
        8.2.3 Asia-Pacific Crohn’s Disease Therapeutics Market Share by Type (2017-2028)
    8.3 Asia-Pacific Crohn’s Disease Therapeutics Market Size by Application
        8.3.1 Asia-Pacific Crohn’s Disease Therapeutics Market Size by Application (2017-2022)
        8.3.2 Asia-Pacific Crohn’s Disease Therapeutics Market Size by Application (2023-2028)
        8.3.3 Asia-Pacific Crohn’s Disease Therapeutics Market Share by Application (2017-2028)
    8.4 Asia-Pacific Crohn’s Disease Therapeutics Market Size by Region
        8.4.1 Asia-Pacific Crohn’s Disease Therapeutics Market Size by Region (2017-2022)
        8.4.2 Asia-Pacific Crohn’s Disease Therapeutics Market Size by Region (2023-2028)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia 
9 Latin America
    9.1 Latin America Crohn’s Disease Therapeutics Market Size (2017-2028)
    9.2 Latin America Crohn’s Disease Therapeutics Market Size by Type
        9.2.1 Latin America Crohn’s Disease Therapeutics Market Size by Type (2017-2022)
        9.2.2 Latin America Crohn’s Disease Therapeutics Market Size by Type (2023-2028)
        9.2.3 Latin America Crohn’s Disease Therapeutics Market Share by Type (2017-2028)
    9.3 Latin America Crohn’s Disease Therapeutics Market Size by Application
        9.3.1 Latin America Crohn’s Disease Therapeutics Market Size by Application (2017-2022)
        9.3.2 Latin America Crohn’s Disease Therapeutics Market Size by Application (2023-2028)
        9.3.3 Latin America Crohn’s Disease Therapeutics Market Share by Application (2017-2028)
    9.4 Latin America Crohn’s Disease Therapeutics Market Size by Country
        9.4.1 Latin America Crohn’s Disease Therapeutics Market Size by Country (2017-2022)
        9.4.2 Latin America Crohn’s Disease Therapeutics Market Size by Country (2023-2028)
        9.4.3 Mexico
        9.4.4 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Crohn’s Disease Therapeutics Market Size (2017-2028)
    10.2 Middle East & Africa Crohn’s Disease Therapeutics Market Size by Type
        10.2.1 Middle East & Africa Crohn’s Disease Therapeutics Market Size by Type (2017-2022)
        10.2.2 Middle East & Africa Crohn’s Disease Therapeutics Market Size by Type (2023-2028)
        10.2.3 Middle East & Africa Crohn’s Disease Therapeutics Market Share by Type (2017-2028)
    10.3 Middle East & Africa Crohn’s Disease Therapeutics Market Size by Application
        10.3.1 Middle East & Africa Crohn’s Disease Therapeutics Market Size by Application (2017-2022)
        10.3.2 Middle East & Africa Crohn’s Disease Therapeutics Market Size by Application (2023-2028)
        10.3.3 Middle East & Africa Crohn’s Disease Therapeutics Market Share by Application (2017-2028)
    10.4 Middle East & Africa Crohn’s Disease Therapeutics Market Size by Country
        10.4.1 Middle East & Africa Crohn’s Disease Therapeutics Market Size by Country (2017-2022)
        10.4.2 Middle East & Africa Crohn’s Disease Therapeutics Market Size by Country (2023-2028)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE
11 Key Players Profiles
    11.1 Johnson and Johnson Services Inc.
        11.1.1 Johnson and Johnson Services Inc. Company Details
        11.1.2 Johnson and Johnson Services Inc. Business Overview
        11.1.3 Johnson and Johnson Services Inc. Crohn’s Disease Therapeutics Introduction
        11.1.4 Johnson and Johnson Services Inc. Revenue in Crohn’s Disease Therapeutics Business (2017-2022)
        11.1.5 Johnson and Johnson Services Inc. Recent Developments
    11.2 Pfizer Inc.
        11.2.1 Pfizer Inc. Company Details
        11.2.2 Pfizer Inc. Business Overview
        11.2.3 Pfizer Inc. Crohn’s Disease Therapeutics Introduction
        11.2.4 Pfizer Inc. Revenue in Crohn’s Disease Therapeutics Business (2017-2022)
        11.2.5 Pfizer Inc. Recent Developments
    11.3 Allergan
        11.3.1 Allergan Company Details
        11.3.2 Allergan Business Overview
        11.3.3 Allergan Crohn’s Disease Therapeutics Introduction
        11.3.4 Allergan Revenue in Crohn’s Disease Therapeutics Business (2017-2022)
        11.3.5 Allergan Recent Developments
    11.4 AbbVie Inc.
        11.4.1 AbbVie Inc. Company Details
        11.4.2 AbbVie Inc. Business Overview
        11.4.3 AbbVie Inc. Crohn’s Disease Therapeutics Introduction
        11.4.4 AbbVie Inc. Revenue in Crohn’s Disease Therapeutics Business (2017-2022)
        11.4.5 AbbVie Inc. Recent Developments
    11.5 Takeda Pharmaceutical Company Limited
        11.5.1 Takeda Pharmaceutical Company Limited Company Details
        11.5.2 Takeda Pharmaceutical Company Limited Business Overview
        11.5.3 Takeda Pharmaceutical Company Limited Crohn’s Disease Therapeutics Introduction
        11.5.4 Takeda Pharmaceutical Company Limited Revenue in Crohn’s Disease Therapeutics Business (2017-2022)
        11.5.5 Takeda Pharmaceutical Company Limited Recent Developments
    11.6 Celgene Corporation
        11.6.1 Celgene Corporation Company Details
        11.6.2 Celgene Corporation Business Overview
        11.6.3 Celgene Corporation Crohn’s Disease Therapeutics Introduction
        11.6.4 Celgene Corporation Revenue in Crohn’s Disease Therapeutics Business (2017-2022)
        11.6.5 Celgene Corporation Recent Developments
    11.7 Perrigo Company PLC
        11.7.1 Perrigo Company PLC Company Details
        11.7.2 Perrigo Company PLC Business Overview
        11.7.3 Perrigo Company PLC Crohn’s Disease Therapeutics Introduction
        11.7.4 Perrigo Company PLC Revenue in Crohn’s Disease Therapeutics Business (2017-2022)
        11.7.5 Perrigo Company PLC Recent Developments
    11.8 Ferring B.V.
        11.8.1 Ferring B.V. Company Details
        11.8.2 Ferring B.V. Business Overview
        11.8.3 Ferring B.V. Crohn’s Disease Therapeutics Introduction
        11.8.4 Ferring B.V. Revenue in Crohn’s Disease Therapeutics Business (2017-2022)
        11.8.5 Ferring B.V. Recent Developments
    11.9 Salix Pharmaceuticals
        11.9.1 Salix Pharmaceuticals Company Details
        11.9.2 Salix Pharmaceuticals Business Overview
        11.9.3 Salix Pharmaceuticals Crohn’s Disease Therapeutics Introduction
        11.9.4 Salix Pharmaceuticals Revenue in Crohn’s Disease Therapeutics Business (2017-2022)
        11.9.5 Salix Pharmaceuticals Recent Developments
    11.10 Gilead Sciences Inc.
        11.10.1 Gilead Sciences Inc. Company Details
        11.10.2 Gilead Sciences Inc. Business Overview
        11.10.3 Gilead Sciences Inc. Crohn’s Disease Therapeutics Introduction
        11.10.4 Gilead Sciences Inc. Revenue in Crohn’s Disease Therapeutics Business (2017-2022)
        11.10.5 Gilead Sciences Inc. Recent Developments
    11.11 Genentech Inc.
        11.11.1 Genentech Inc. Company Details
        11.11.2 Genentech Inc. Business Overview
        11.11.3 Genentech Inc. Crohn’s Disease Therapeutics Introduction
        11.11.4 Genentech Inc. Revenue in Crohn’s Disease Therapeutics Business (2017-2022)
        11.11.5 Genentech Inc. Recent Developments
    11.12 UCB India Private Limited.
        11.12.1 UCB India Private Limited. Company Details
        11.12.2 UCB India Private Limited. Business Overview
        11.12.3 UCB India Private Limited. Crohn’s Disease Therapeutics Introduction
        11.12.4 UCB India Private Limited. Revenue in Crohn’s Disease Therapeutics Business (2017-2022)
        11.12.5 UCB India Private Limited. Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Author Details
    13.3 Disclaimer

List of Tables
    Table 1. Global Crohn’s Disease Therapeutics Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of Non-Surgical
    Table 3. Key Players of Surgical
    Table 4. Global Crohn’s Disease Therapeutics Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 5. Global Crohn’s Disease Therapeutics Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 6. Global Crohn’s Disease Therapeutics Market Size by Region (2017-2022) & (US$ Million)
    Table 7. Global Crohn’s Disease Therapeutics Market Share by Region (2017-2022)
    Table 8. Global Crohn’s Disease Therapeutics Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 9. Global Crohn’s Disease Therapeutics Market Share by Region (2023-2028)
    Table 10. Crohn’s Disease Therapeutics Market Trends
    Table 11. Crohn’s Disease Therapeutics Market Drivers
    Table 12. Crohn’s Disease Therapeutics Market Challenges
    Table 13. Crohn’s Disease Therapeutics Market Restraints
    Table 14. Global Crohn’s Disease Therapeutics Revenue by Players (2017-2022) & (US$ Million)
    Table 15. Global Crohn’s Disease Therapeutics Revenue Share by Players (2017-2022)
    Table 16. Global Top Crohn’s Disease Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Crohn’s Disease Therapeutics as of 2021)
    Table 17. Ranking of Global Top Crohn’s Disease Therapeutics Companies by Revenue (US$ Million) in 2021
    Table 18. Global 5 Largest Players Market Share by Crohn’s Disease Therapeutics Revenue (CR5 and HHI) & (2017-2022)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Crohn’s Disease Therapeutics Product Solution and Service
    Table 21. Date of Enter into Crohn’s Disease Therapeutics Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Crohn’s Disease Therapeutics Market Size by Type (2017-2022) & (US$ Million)
    Table 24. Global Crohn’s Disease Therapeutics Revenue Market Share by Type (2017-2022)
    Table 25. Global Crohn’s Disease Therapeutics Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 26. Global Crohn’s Disease Therapeutics Revenue Market Share by Type (2023-2028)
    Table 27. Global Crohn’s Disease Therapeutics Market Size by Application (2017-2022) & (US$ Million)
    Table 28. Global Crohn’s Disease Therapeutics Revenue Share by Application (2017-2022)
    Table 29. Global Crohn’s Disease Therapeutics Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 30. Global Crohn’s Disease Therapeutics Revenue Share by Application (2023-2028)
    Table 31. North America Crohn’s Disease Therapeutics Market Size by Type (2017-2022) & (US$ Million)
    Table 32. North America Crohn’s Disease Therapeutics Market Size by Type (2023-2028) & (US$ Million)
    Table 33. North America Crohn’s Disease Therapeutics Market Size by Application (2017-2022) & (US$ Million)
    Table 34. North America Crohn’s Disease Therapeutics Market Size by Application (2023-2028) & (US$ Million)
    Table 35. North America Crohn’s Disease Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 36. North America Crohn’s Disease Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 37. Europe Crohn’s Disease Therapeutics Market Size by Type (2017-2022) & (US$ Million)
    Table 38. Europe Crohn’s Disease Therapeutics Market Size by Type (2023-2028) & (US$ Million)
    Table 39. Europe Crohn’s Disease Therapeutics Market Size by Application (2017-2022) & (US$ Million)
    Table 40. Europe Crohn’s Disease Therapeutics Market Size by Application (2023-2028) & (US$ Million)
    Table 41. Europe Crohn’s Disease Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 42. Europe Crohn’s Disease Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 43. Asia Pacific Crohn’s Disease Therapeutics Market Size by Type (2017-2022) & (US$ Million)
    Table 44. Asia Pacific Crohn’s Disease Therapeutics Market Size by Type (2023-2028) & (US$ Million)
    Table 45. Asia Pacific Crohn’s Disease Therapeutics Market Size by Application (2017-2022) & (US$ Million)
    Table 46. Asia Pacific Crohn’s Disease Therapeutics Market Size by Application (2023-2028) & (US$ Million)
    Table 47. Asia Pacific Crohn’s Disease Therapeutics Market Size by Region (2017-2022) & (US$ Million)
    Table 48. Asia Pacific Crohn’s Disease Therapeutics Market Size by Region (2023-2028) & (US$ Million)
    Table 49. Latin America Crohn’s Disease Therapeutics Market Size by Type (2017-2022) & (US$ Million)
    Table 50. Latin America Crohn’s Disease Therapeutics Market Size by Type (2023-2028) & (US$ Million)
    Table 51. Latin America Crohn’s Disease Therapeutics Market Size by Application (2017-2022) & (US$ Million)
    Table 52. Latin America Crohn’s Disease Therapeutics Market Size by Application (2023-2028) & (US$ Million)
    Table 53. Latin America Crohn’s Disease Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 54. Latin America Crohn’s Disease Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 55. Middle East and Africa Crohn’s Disease Therapeutics Market Size by Type (2017-2022) & (US$ Million)
    Table 56. Middle East and Africa Crohn’s Disease Therapeutics Market Size by Type (2023-2028) & (US$ Million)
    Table 57. Middle East and Africa Crohn’s Disease Therapeutics Market Size by Application (2017-2022) & (US$ Million)
    Table 58. Middle East and Africa Crohn’s Disease Therapeutics Market Size by Application (2023-2028) & (US$ Million)
    Table 59. Middle East and Africa Crohn’s Disease Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 60. Middle East and Africa Crohn’s Disease Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 61. Johnson and Johnson Services Inc. Company Details
    Table 62. Johnson and Johnson Services Inc. Business Overview
    Table 63. Johnson and Johnson Services Inc. Crohn’s Disease Therapeutics Product
    Table 64. Johnson and Johnson Services Inc. Revenue in Crohn’s Disease Therapeutics Business (2017-2022) & (US$ Million)
    Table 65. Johnson and Johnson Services Inc. Recent Developments
    Table 66. Pfizer Inc. Company Details
    Table 67. Pfizer Inc. Business Overview
    Table 68. Pfizer Inc. Crohn’s Disease Therapeutics Product
    Table 69. Pfizer Inc. Revenue in Crohn’s Disease Therapeutics Business (2017-2022) & (US$ Million)
    Table 70. Pfizer Inc. Recent Developments
    Table 71. Allergan Company Details
    Table 72. Allergan Business Overview
    Table 73. Allergan Crohn’s Disease Therapeutics Product
    Table 74. Allergan Revenue in Crohn’s Disease Therapeutics Business (2017-2022) & (US$ Million)
    Table 75. Allergan Recent Developments
    Table 76. AbbVie Inc. Company Details
    Table 77. AbbVie Inc. Business Overview
    Table 78. AbbVie Inc. Crohn’s Disease Therapeutics Product
    Table 79. AbbVie Inc. Revenue in Crohn’s Disease Therapeutics Business (2017-2022) & (US$ Million)
    Table 80. AbbVie Inc. Recent Developments
    Table 81. Takeda Pharmaceutical Company Limited Company Details
    Table 82. Takeda Pharmaceutical Company Limited Business Overview
    Table 83. Takeda Pharmaceutical Company Limited Crohn’s Disease Therapeutics Product
    Table 84. Takeda Pharmaceutical Company Limited Revenue in Crohn’s Disease Therapeutics Business (2017-2022) & (US$ Million)
    Table 85. Takeda Pharmaceutical Company Limited Recent Developments
    Table 86. Celgene Corporation Company Details
    Table 87. Celgene Corporation Business Overview
    Table 88. Celgene Corporation Crohn’s Disease Therapeutics Product
    Table 89. Celgene Corporation Revenue in Crohn’s Disease Therapeutics Business (2017-2022) & (US$ Million)
    Table 90. Celgene Corporation Recent Developments
    Table 91. Perrigo Company PLC Company Details
    Table 92. Perrigo Company PLC Business Overview
    Table 93. Perrigo Company PLC Crohn’s Disease Therapeutics Product
    Table 94. Perrigo Company PLC Revenue in Crohn’s Disease Therapeutics Business (2017-2022) & (US$ Million)
    Table 95. Perrigo Company PLC Recent Developments
    Table 96. Ferring B.V. Company Details
    Table 97. Ferring B.V. Business Overview
    Table 98. Ferring B.V. Crohn’s Disease Therapeutics Product
    Table 99. Ferring B.V. Revenue in Crohn’s Disease Therapeutics Business (2017-2022) & (US$ Million)
    Table 100. Ferring B.V. Recent Developments
    Table 101. Salix Pharmaceuticals Company Details
    Table 102. Salix Pharmaceuticals Business Overview
    Table 103. Salix Pharmaceuticals Crohn’s Disease Therapeutics Product
    Table 104. Salix Pharmaceuticals Revenue in Crohn’s Disease Therapeutics Business (2017-2022) & (US$ Million)
    Table 105. Salix Pharmaceuticals Recent Developments
    Table 106. Gilead Sciences Inc. Company Details
    Table 107. Gilead Sciences Inc. Business Overview
    Table 108. Gilead Sciences Inc. Crohn’s Disease Therapeutics Product
    Table 109. Gilead Sciences Inc. Revenue in Crohn’s Disease Therapeutics Business (2017-2022) & (US$ Million)
    Table 110. Gilead Sciences Inc. Recent Developments
    Table 111. Genentech Inc. Company Details
    Table 112. Genentech Inc. Business Overview
    Table 113. Genentech Inc. Crohn’s Disease Therapeutics Product
    Table 114. Genentech Inc. Revenue in Crohn’s Disease Therapeutics Business (2017-2022) & (US$ Million)
    Table 115. Genentech Inc. Recent Developments
    Table 116. UCB India Private Limited. Company Details
    Table 117. UCB India Private Limited. Business Overview
    Table 118. UCB India Private Limited. Crohn’s Disease Therapeutics Product
    Table 119. UCB India Private Limited. Revenue in Crohn’s Disease Therapeutics Business (2017-2022) & (US$ Million)
    Table 120. UCB India Private Limited. Recent Developments
    Table 121. Research Programs/Design for This Report
    Table 122. Key Data Information from Secondary Sources
    Table 123. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Crohn’s Disease Therapeutics Market Share by Type: 2021 VS 2028
    Figure 2. Non-Surgical Features
    Figure 3. Surgical Features
    Figure 4. Global Crohn’s Disease Therapeutics Market Share by Application: 2021 VS 2028
    Figure 5. Hospitals Case Studies
    Figure 6. Ambulatory Surgical Centers Case Studies
    Figure 7. Crohn’s Disease Therapeutics Report Years Considered
    Figure 8. Global Crohn’s Disease Therapeutics Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 9. Global Crohn’s Disease Therapeutics Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 10. Global Crohn’s Disease Therapeutics Market Share by Region: 2021 VS 2028
    Figure 11. Global Crohn’s Disease Therapeutics Market Share by Players in 2021
    Figure 12. Global Top Crohn’s Disease Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Crohn’s Disease Therapeutics as of 2021)
    Figure 13. The Top 10 and 5 Players Market Share by Crohn’s Disease Therapeutics Revenue in 2021
    Figure 14. North America Crohn’s Disease Therapeutics Market Size YoY (2017-2028) & (US$ Million)
    Figure 15. North America Crohn’s Disease Therapeutics Market Size Market Share by Type (2017-2028)
    Figure 16. North America Crohn’s Disease Therapeutics Market Size Market Share by Application (2017-2028)
    Figure 17. North America Crohn’s Disease Therapeutics Market Size Share by Country (2017-2028)
    Figure 18. United States Crohn’s Disease Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 19. Canada Crohn’s Disease Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. Europe Crohn’s Disease Therapeutics Market Size YoY (2017-2028) & (US$ Million)
    Figure 21. Europe Crohn’s Disease Therapeutics Market Size Market Share by Type (2017-2028)
    Figure 22. Europe Crohn’s Disease Therapeutics Market Size Market Share by Application (2017-2028)
    Figure 23. Europe Crohn’s Disease Therapeutics Market Size Share by Country (2017-2028)
    Figure 24. Germany Crohn’s Disease Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. France Crohn’s Disease Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. U.K. Crohn’s Disease Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Italy Crohn’s Disease Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Russia Crohn’s Disease Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Nordic Countries Crohn’s Disease Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Asia-Pacific Crohn’s Disease Therapeutics Market Size YoY (2017-2028) & (US$ Million)
    Figure 31. Asia Pacific Crohn’s Disease Therapeutics Market Size Market Share by Type (2017-2028)
    Figure 32. Asia Pacific Crohn’s Disease Therapeutics Market Size Market Share by Application (2017-2028)
    Figure 33. Asia Pacific Crohn’s Disease Therapeutics Market Size Share by Region (2017-2028)
    Figure 34. China Crohn’s Disease Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Japan Crohn’s Disease Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. South Korea Crohn’s Disease Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Southeast Asia Crohn’s Disease Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. India Crohn’s Disease Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Australia Crohn’s Disease Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
    Figure 40. Latin America Crohn’s Disease Therapeutics Market Size YoY (2017-2028) & (US$ Million)
    Figure 41. Latin America Crohn’s Disease Therapeutics Market Size Market Share by Type (2017-2028)
    Figure 42. Latin America Crohn’s Disease Therapeutics Market Size Market Share by Application (2017-2028)
    Figure 43. Latin America Crohn’s Disease Therapeutics Market Size Share by Country (2017-2028)
    Figure 44. Mexico Crohn’s Disease Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 45. Brazil Crohn’s Disease Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 46. Middle East & Africa Crohn’s Disease Therapeutics Market Size YoY (2017-2028) & (US$ Million)
    Figure 47. Middle East and Africa Crohn’s Disease Therapeutics Market Size Market Share by Type (2017-2028)
    Figure 48. Middle East and Africa Crohn’s Disease Therapeutics Market Size Market Share by Application (2017-2028)
    Figure 49. Middle East and Africa Crohn’s Disease Therapeutics Market Size Share by Country (2017-2028)
    Figure 50. Turkey Crohn’s Disease Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 51. Saudi Arabia Crohn’s Disease Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 52. UAE Crohn’s Disease Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 53. Johnson and Johnson Services Inc. Revenue Growth Rate in Crohn’s Disease Therapeutics Business (2017-2022)
    Figure 54. Pfizer Inc. Revenue Growth Rate in Crohn’s Disease Therapeutics Business (2017-2022)
    Figure 55. Allergan Revenue Growth Rate in Crohn’s Disease Therapeutics Business (2017-2022)
    Figure 56. AbbVie Inc. Revenue Growth Rate in Crohn’s Disease Therapeutics Business (2017-2022)
    Figure 57. Takeda Pharmaceutical Company Limited Revenue Growth Rate in Crohn’s Disease Therapeutics Business (2017-2022)
    Figure 58. Celgene Corporation Revenue Growth Rate in Crohn’s Disease Therapeutics Business (2017-2022)
    Figure 59. Perrigo Company PLC Revenue Growth Rate in Crohn’s Disease Therapeutics Business (2017-2022)
    Figure 60. Ferring B.V. Revenue Growth Rate in Crohn’s Disease Therapeutics Business (2017-2022)
    Figure 61. Salix Pharmaceuticals Revenue Growth Rate in Crohn’s Disease Therapeutics Business (2017-2022)
    Figure 62. Gilead Sciences Inc. Revenue Growth Rate in Crohn’s Disease Therapeutics Business (2017-2022)
    Figure 63. Genentech Inc. Revenue Growth Rate in Crohn’s Disease Therapeutics Business (2017-2022)
    Figure 64. UCB India Private Limited. Revenue Growth Rate in Crohn’s Disease Therapeutics Business (2017-2022)
    Figure 65. Bottom-up and Top-down Approaches for This Report
    Figure 66. Data Triangulation
    Figure 67. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Johnson and Johnson Services Inc.
Pfizer Inc.
Allergan
AbbVie Inc.
Takeda Pharmaceutical Company Limited
Celgene Corporation
Perrigo Company PLC
Ferring B.V.
Salix Pharmaceuticals
Gilead Sciences Inc.
Genentech Inc.
UCB India Private Limited.
Frequently Asked Questions
Crohn’s Disease Therapeutics report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Crohn’s Disease Therapeutics report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Crohn’s Disease Therapeutics report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports